Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adrenoceptor alpha 2C | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 2A | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 2B | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Agonist activity at human adrenergic alpha2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry | ChEMBL. | 15566287 | |
Activity (functional) | Agonist activity at human adrenergic alpha2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry | ChEMBL. | 15566287 | |
Activity (functional) | 0 | Agonist activity at human adrenergic alpha2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry | ChEMBL. | 15566287 |
Activity (functional) | 0 | Agonist activity at human adrenergic alpha2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry | ChEMBL. | 15566287 |
EC50 (functional) | = -6.44 | Agonist activity at human adrenergic alpha2C receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry | ChEMBL. | 15566287 |
Intrinsic activity (functional) | < 0.3 | Agonist activity at human adrenergic alpha2B receptor expressed in CHO cells assessed as extracellular acidification relative to noradrenaline by cytosensor microphysiometry | ChEMBL. | 15566287 |
Intrinsic activity (functional) | < 0.3 | Agonist activity at human adrenergic alpha2A receptor expressed in CHO cells assessed as extracellular acidification relative to noradrenaline by cytosensor microphysiometry | ChEMBL. | 15566287 |
Intrinsic activity (functional) | = 0.45 | Agonist activity at human adrenergic alpha2C receptor expressed in CHO cells assessed as extracellular acidification relative to noradrenaline by cytosensor microphysiometry | ChEMBL. | 15566287 |
Intrinsic activity (functional) | < 0.3 | Agonist activity at human adrenergic alpha2B receptor expressed in CHO cells assessed as extracellular acidification relative to noradrenaline by cytosensor microphysiometry | ChEMBL. | 15566287 |
Intrinsic activity (functional) | < 0.3 | Agonist activity at human adrenergic alpha2A receptor expressed in CHO cells assessed as extracellular acidification relative to noradrenaline by cytosensor microphysiometry | ChEMBL. | 15566287 |
Intrinsic activity (functional) | = 0.45 | Agonist activity at human adrenergic alpha2C receptor expressed in CHO cells assessed as extracellular acidification relative to noradrenaline by cytosensor microphysiometry | ChEMBL. | 15566287 |
Ki (binding) | = -7.33 | Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells | ChEMBL. | 15566287 |
Ki (binding) | = -6.63 | Displacement of [3H]RX821002 from human adrenergic alpha2C receptor expressed in CHO cells | ChEMBL. | 15566287 |
Ki (binding) | = -6.08 | Displacement of [3H]RX821002 from human adrenergic alpha2B receptor expressed in CHO cells | ChEMBL. | 15566287 |
Log EC50 (functional) | = 6.44 | Agonist activity at human adrenergic alpha2C receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry | ChEMBL. | 15566287 |
Log Ki (binding) | = 6.08 | Displacement of [3H]RX821002 from human adrenergic alpha2B receptor expressed in CHO cells | ChEMBL. | 15566287 |
Log Ki (binding) | = 6.63 | Displacement of [3H]RX821002 from human adrenergic alpha2C receptor expressed in CHO cells | ChEMBL. | 15566287 |
Log Ki (binding) | = 7.33 | Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells | ChEMBL. | 15566287 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.